Login to Your Account



Cypress Relents on New Offer from Ramius, Royalty Pharma

By Catherine Shaffer


Thursday, December 16, 2010
Ramius V&O Acquisition LLC and Royalty Pharma, of New York, will acquire Cypress Bioscience Inc., of San Diego, in an all-cash transaction worth approximately $255 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription